Quick Answer
STANDARD BIOTOOLS INC. reported Operating Income of -$110.25 million for fiscal year 2025.
STANDARD BIOTOOLS INC. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$110.25M | +13.5% |
| 2024 | -$127.48M | -66.4% |
| 2023 | -$76.60M | +34.1% |
| 2022 | -$116.20M | -72.3% |
| 2021 | -$67.46M | -32.2% |
| 2020 | -$51.04M | +1.5% |
| 2019 | -$51.84M | -7.6% |
| 2018 | -$48.16M | +17.5% |
| 2017 | -$58.36M | +20.3% |
| 2016 | -$73.19M | -45.9% |
| 2015 | -$50.16M | +3.2% |
| 2014 | -$51.84M | -177.9% |
| 2013 | -$18.65M | -3.2% |
| 2012 | -$18.07M | +2.7% |
| 2011 | -$18.57M | -27.4% |
| 2010 | -$14.57M | +19.2% |
| 2009 | -$18.04M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$32.94M | -23.4% | -28.2% |
| June 30, 2025 | -$25.70M | +15.1% | +22.1% |
| March 31, 2025 | -$32.97M | +45.2% | -23.5% |
| September 30, 2024 | -$26.70M | -26.1% | +11.8% |
| June 30, 2024 | -$30.26M | -73.4% | +49.7% |
| March 31, 2024 | -$60.18M | -262.7% | -184.3% |
| September 30, 2023 | -$21.17M | +27.1% | -21.3% |
| June 30, 2023 | -$17.45M | +54.8% | -5.2% |
- STANDARD BIOTOOLS INC. showed an increase of +13.5% in Operating Income compared to the prior fiscal year.
- Over the 2009–2025 period, STANDARD BIOTOOLS INC.’s operating income has declined by 511.2% (from -$18.04 million to -$110.25 million).
- The most recent figure is from STANDARD BIOTOOLS INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 16, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: